Your browser doesn't support javascript.
loading
Retraction notice to "Corrigendum to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78]" [EBioMedicine 55 (2020) 102772].
Wang, Wei-Wei; Zhao, Zhi-Hua; Wang, Li; Li, Pan; Chen, Kui-Sheng; Zhang, Jian-Ying; Li, Wen-Cai; Jiang, Guo-Zhong; Li, Xiang-Nan.
Affiliation
  • Wang WW; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China; Department of Pathology, School of Basic Medicine, Zhengzhou University, Zhengzhou, 450002, China; Henan Key Laboratory for Tumor Pathology, Zhengzhou, 450052, China.
  • Zhao ZH; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China; Department of Pathology, School of Basic Medicine, Zhengzhou University, Zhengzhou, 450002, China; Henan Key Laboratory for Tumor Pathology, Zhengzhou, 450052, China.
  • Wang L; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China; Department of Pathology, School of Basic Medicine, Zhengzhou University, Zhengzhou, 450002, China; Henan Key Laboratory for Tumor Pathology, Zhengzhou, 450052, China.
  • Li P; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China; Department of Pathology, School of Basic Medicine, Zhengzhou University, Zhengzhou, 450002, China; Henan Key Laboratory for Tumor Pathology, Zhengzhou, 450052, China.
  • Chen KS; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China; Department of Pathology, School of Basic Medicine, Zhengzhou University, Zhengzhou, 450002, China; Henan Key Laboratory for Tumor Pathology, Zhengzhou, 450052, China.
  • Zhang JY; Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450052, China.
  • Li WC; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China; Department of Pathology, School of Basic Medicine, Zhengzhou University, Zhengzhou, 450002, China; Henan Key Laboratory for Tumor Pathology, Zhengzhou, 450052, China. Electronic address: liwenca
  • Jiang GZ; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China; Department of Pathology, School of Basic Medicine, Zhengzhou University, Zhengzhou, 450002, China; Henan Key Laboratory for Tumor Pathology, Zhengzhou, 450052, China. Electronic address: guozhon
  • Li XN; Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. Electronic address: fcclixn@zzu.edu.cn.
EBioMedicine ; 103: 105106, 2024 05.
Article de En | MEDLINE | ID: mdl-38579361

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: EBioMedicine Année: 2024 Type de document: Article Pays d'affiliation: Chine

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: EBioMedicine Année: 2024 Type de document: Article Pays d'affiliation: Chine